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THE SOUTH CAROLINA TELESTROKE PROGRAM:
DOES COUNTY-LEVEL TELESTROKE ACCESS INCREASE THE ODDS THAT
PATIENTS WILL RECEIVE T-PA?

Steven M. DiLembo
Chairperson: Dr. Annie Simpson
Committee: Dr. Jillian Harvey
Committee: Dr. Mark Persin
Stroke is a disease that is responsible for disabling more of its victims that any
other disease in the United States. There are four types of stroke. However, ischemic
stroke is responsible for 87% of all strokes. T-PA is a pharmaceutical that has proven an
effective treatment for ischemic stroke patients since 1996. T-PA works by dissolving the
thrombosis that has become lodged in a brain vessel. This pharmaceutical has its
limitations; mainly it must be administered within 4.5 hours of symptom onset.
Nationally, the medical field experiences low utilization rates, between 3-5%. The many
variables that affect this low usage rate, however, this study focuses on patient’s
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residence in a county that offers telestroke services compared to counties that do not have
telestroke services.
In completion, of the necessary research, archival data from the 2013 Healthcare Cost
and Utilization Project (HCUP) State Inpatient Database (SID) for South Carolina was
utilized. Hospital encounters that had a primary diagnosis code of 424.xx & 436.xx (ICD9-CM) were identified for analysis. The analysis revealed 9,311 South Carolinians
suffered a stroke in 2013 while a total of 461 patients were administered t-PA (4.95%).
The study found a greater percentage of patients living in “Telestroke Access” counties
received t-PA compared to those that did not, 5.11% to 4.76%, respectively. However,
the county in which patients resides was not a statistically significant indicator because of
the p-value = 0.36.
Keywords: Telestroke, ischemic stroke, barriers in telestroke, tissue plasminogen
activase, telestroke effectiveness, benefits of telestroke, treatments of acute ischemic
stroke, and utilization rates of t-pa
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CHAPTER 1: INTRODUCTION
Stroke is a disease that is responsible for causing more disability to its victims
than any other disease (Silva & Schwamm, 2012). In the United States alone, 780,000
strokes occur annually. In 2014, it was the cause of death in 1 in 16 people. (Kazley,
Simpson, K., Simpson, A., Jauch, & Adams, 2013). Although there are many different
types of stroke, the type with the highest rate of occurrence is ischemic, comprising 87%
of all strokes (Demaerschalk, Hwang, & Leung, 2010). This type of stroke is responsible
for a large burden on society with; 30% of those who survive become permanently
disabled, and 20% require inpatient care for three-months post event. Not only is this
costly for the patient, but also costly on society. In 2008, indirect and direct costs
associated with stroke totaled $65.5 billion dollars (Demaerschalk, Hwang, & Leung,
2010). The amount cited above is important, because the majority of people who suffer a
stroke have their health care financed by the American taxpayer through Medicare
(Bonilha et al., 2011). Obviously, something needs to be done to reduce the impact stroke
has on patients and society.
In 1996, the FDA approved a revolutionary treatment for stroke a named
pharmaceutical called Tissue Plasminogen Activator (t-PA), which is a thrombolytic
agent—working to dissolve the clot in the patient’s vessel inside the brain. T-PA has
been used with great success over the years, but due to its strict indications for use, only
3-5% of stroke patients receive t-PA in the United States. The factor most responsible for
its limited utilization is the limited period in which t-PA can be administered after initial
onset of stroke symptoms, which is no more than 4.5 hours. This window may seem
sufficient to some, however, taking in consideration the events leading up to t-PA
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administration often takes many hours (Sliva & Schwamm, 2012). Recognition of
symptoms occurs by oneself, family, friends, or medical professionals. The FAST
method facilitates early identification of stroke symptoms: F (Face Dropping), A (Arm
Weakness), S (Speech Difficulty), T (Time to Call 911) acronym. If the patient is not
already under the care of medical professionals the order of events consists of the
following: alerting first responders, travel time to a medical facility, entering the
Emergency Department, triage, rooming, further assessment, diagnostic tests, and
eventually administering t-PA. In addition to the time constraint, other barriers exist to
receiving t-PA, such as the availability of the thrombolytic agent or of trained staff in
house to assess, diagnose, and treat stroke patients. If the facility does not have access to
the medication, it would not be possible for the patient to receive it, even if the patient
was assessed and the decision to administer t-PA was made. Additionally, the lack of
specially trained neurologists or emergency medical physicians in the facility when a
stroke patient arrives also prevents or lowers the likelihood of t-PA administration (Silva
& Schwamm, 2012).
A potential solution to this problem is to utilize technology to improve the access
to specialty stroke providers and bring the highly-specialized stroke specialists to the
patient’s bedside, regardless of distance. The solution is commonly referred to as
telestroke. The term telestroke is a broad term and is defined differently by many
agencies, some of which will be described later. However, telestroke can be used as a tool
to foster greater rates of administration in this nation’s stroke patient population,
increasing the 3-5% national benchmark. For example, a study in South Carolina on
REACH-MUSC reported a 35.7% rate of t-PA administration following telestroke care
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(Lazaridis, DeSantis, Jauch, & Adams, 2013). The goal of this work is to investigate
differing rates of t-PA administration based on the proximity of the patient to a medical
facility prepared to treat stroke patients. If the rates are shown to increase compared to
national averages in areas with greater accessibility, and stakeholder insurers, both public
and private, reimburse for this type of telehealth service, more hospitals would designate
the capital necessary to implement this technological solution. However, to support this
argument more research must be conducted to show the utility of telemedicine or
telestroke. The question this study will answer is if patients that live in counties offering
telestroke services realize higher rates of t-PA administration compared to patients who
live in counties that do not offer telestroke services.
To accomplish this goal, one must review the current literature available
surrounding the major topics related to stroke and its effects on society and family, t-PA,
telehealth, barriers to adoption, and others pertinent topics. The goal is to bring awareness
to the national community of caregivers, insurers, and policy-makers with the purpose of
fostering change and saving lives and financial resources.
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CHAPTER 2: LITERATURE REVIEW
Impact on Society:
According to various sources, stroke is the fourth most common cause of humans
and third most common killer of Americans (Joubert J. et al., 2008), behind heart disease
and cancer in 2004 (Demaerschalk, Hwang, & Leung, 2010). Stroke affects 780,000
people in the United States per year (Demaerschalk, Hwang, & Leung, 2010), costing the
American public roughly $65.5 billion dollars (Demaerschalk, Hwang, & Leung, 2010).
Stroke is also the leading cause of long-term disability in the United States; 30% of
stroke survivors suffer from permanent disability, while 20% will require institutional
care three-month post event (Demaerschalk, Hwang, & Leung, 2010). It is important to
note these figures do not include individuals who succumb to this event and die.
Two types of stroke are responsible for the enormous amount of affected lives and
money spent—ischemic and hemorrhagic. Ischemic stroke is the most common,
comprising 78% of all strokes; hemorrhagic strokes comprise 22% (Demaerschalk,
Hwang, & Leung, 2010). It is astounding the impact stroke has on society as a whole; the
figures above describe this fact. However, what they do not describe is the effect on the
family of those who suffer from stroke.
Impact on Family:
Families of stroke victims are affected in many ways. Those who experience a
loved one dying from stroke suffer from the loss of life. At times the death alone is not
the only impact. When the deceased was a source of funding for the family, such as a
working mother or father, the family must adjust not only to the death of a loved one but
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also the lost income. If the deceased leaves children behind, someone must raise the
children, or the children will suffer from lost guidance and parenting.
As the statistics indicate not all stroke victims succumb to death. Many of the
survivors face the long-term effects of the disease. The survivors often require care and
assistance with activities of daily living (ADL). These activities, taken for granted before
the occurrence of a stroke, include feeding, dressing, and toileting, which to be addressed
as soon as the patient cannot perform independently. When the survivor suffers from
aphasia, the victim may lose his or her ability to communicate effectively
(Healthclop.com, 2013). Depending on the family’s life situation and severity of the
stroke, family members of the stroke survivor, such as the spouse, adult children, or
parents of the survivor may be thrust into a new role as a caregiver. This change in role
for both the caregiver and survivor often is difficult to handle for both parties. Caregivers
may find themselves withdrawing from life as they knew it to care for their loved one,
sacrificing social, professional, and emotional aspects of their life to provide the level of
required care. Often this change of lifestyle due to the demand of providing varying
degrees of care can negatively impact the caregiver, causing anxiety and depression. At
the time of stroke, the family members are not entirely aware of the resulting level of care
required. Some strokes may be mild while others are debilitating. It may be difficult for
the stroke survivor to accept the care from a spouse, child, or family members due to
previously established family roles. Beyond the potential impacts already listed, new
people who find themselves in the role of the caregiver may see a worsening of their
physical condition, especially when pre-existing conditions are present.
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However, taking on the role of caregiver is not always viewed in a stressful
manner (Gillespie & Campbell, 2011). Instead, some caregivers experience a higher level
of personal importance in their lives and thrive as a result of learning new skills. One
study found, 90% of caregivers developed a greater appreciation for life, 81% reported
that caring for others caused them to feel good about themselves, and 67% expressed
encouragement from the opportunity of learning new skills (Gillespie & Campbell,
2011). Stroke is a disease that can kill, disable, change, and enrich life, but what is a
stroke? How does it affect the body leaving such a lasting impact on the sufferer and
those who develop into caregivers?
Stroke:
“Stroke is a disease that affects the arteries leading to and within the brain” (ASA,
2016, “What is a Stroke?,” para. 2). From this basic definition, there are two types of
stroke, hemorrhagic and ischemic. A hemorrhagic stroke occurs when an artery within
the brain leaks or ruptures. The blood leaked fills areas in the brain cavity, applying
pressure to the brain. This pressure applied to the brain causes brain cell death, resulting
in an intracerebral hemorrhage. Also, similar to the intracerebral hemorrhage, a
subarachnoid hemorrhage is similar, but the blood collects and applies pressure between
the brain and the thin tissue called meninges that covers the brain (CDC, 2016).
The other type of stroke is called ischemic. Ischemic stroke accounts for 85% of
strokes. Ischemic strokes occur when an occlusion occurs in a blood vessel in the brain,
preventing continued blood flow to the areas of the brain beyond the blockage. That
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organic barrier causes cells to starve and eventually die from suffocation or starvation,
resulting in an ischemic stroke (CDC, 2016).
Not as severe as a full ischemic stroke, a Transient Ischemic Attack (TIA) is often
referred to as a mini-stroke. This stroke takes on the same physiological characteristics as
an ischemic stroke. However, the blood flow is only momentarily blocked for anywhere
from a few minutes to a few hours, then blood flow resumes without medical intervention
(CDC, 2016). TIAs are considered a warning for a much larger and threatening stroke
(CDC, 2016). These mini-strokes should be treated with as much caution as a full
ischemic stroke. In fact, the CDC reports greater than a third of people who suffer from a
TIA will have a severe stroke within one year following a TIA if treatment is not received
(CDC, 2016). If treatment is not pursued, 10-15% of these people will suffer a major
stroke within three months of the TIA (CDC, 2016).
Assessment of a Stroke:
The evaluation of a stroke patient is conducted with the use of the NIH Stroke
Scale. The stroke scale is a systematic quantitative neurologic assessment used to
evaluate a patient's level of consciousness, ability to follow commands, facial palsy, and
other post stroke features (Mitka, 2009). When a patient with signs of stroke presents to
an emergency department, a neurologist needs to be consulted to determine the existence
and classification of a suspected stroke. These evaluations can occur utilizing traditional
workup or by using a version of telemedicine known as telestroke. Telestroke is similar
to video conferencing and allows the physician to rapidly examine the patient from a
remote location (Mitka, 2009).
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Physiology of Ischemic Stroke:
An ischemic stroke is general defined as an obstruction in a brain vessel that
prevents blood from freely flowing through, preventing oxygenated and nutrient laden
blood from reaching the areas past the occlusion (ASA, 2016). There are four types of
ischemic strokes: thrombotic, embolic, systemic hypoperfusion, and venous thrombosis
(Deb, Sharma, & Hassan, 2010). In a thrombotic stroke, a thrombus forms in arteries that
supply blood to the brain (Hopkinsmedicine.org, n.d.).
An embolic stroke is similar to a thrombotic but differs in the origin of the clot.
The clot, in this case, develops outside of the brain and is carried to the brain via the
blood stream. The clot could form in the lungs, heart, or other various locations in the
body. Once the clot reaches a vessel, the embolus can no longer continue to flow freely
and becomes lodged, creating a blockage and preventing life sustaining nutrients from
passing further downstream (Mangla, Kolar, Almast, & Ekholm, 2011).
A systemic hypoperfusion or Watershed/Border Zone stroke, is grouped into two
categories. The categories are determined based on the location of the lining of the brain;
external are located in the cortical region while internal occur in the subcortical region
(Mangla, Kolar, Almast, & Ekholm, 2011).
It is hypothesized, “that decreased perfusion in the distal regions of the vascular
territories leaves them vulnerable to infarction. Internal border zone infarcts are
caused mainly by hemodynamic compromise, whereas external border zone
infarcts are believed to result from embolism but not always with associated
hypoperfusion” (Mangla, Kolar, Almast, & Ekholm, 2011, para. 1).

9
Finally, venous thrombosis is similar to a thrombotic stroke except the blocked vessel is
carrying blood to the heart for reoxygenation as the occlusion occurs in a vein. No matter
the type of stroke, the effects are dangerous. According to the neurologist Dr. Kenneth
Gaines, every minute brain cells are starved of oxygen approximately two million cells
die (Morrissey, 2013).
Diagnosis of Acute Ischemic Stroke:
Diagnosis of stroke often begins far from medical professionals and facilities. In
fact, the initial identification of onset is by those around the person at the time of
symptom presentation. The symptoms commonly experienced or observed are facial
palsy (drooping), arm weakness, or slurring of speech. The acronym usually associated
with the presence of these symptoms is F.A.S.T. with the "T” signifying it is time to call
911 (ASA, 2016). Once Emergency Medical Services (EMS) is notified of a possible
stroke, a crew is dispatched within 90 seconds, with the goal of reaching the patient in
less than nine minutes. Upon arrival, the first responders will begin assessing the patient
for the presence and type of stroke. Two of the most commonly used assessment tools are
the Cincinnati Prehospital Stroke Scale (CPSS) and the Los Angeles Prehospital Spinal
Stroke Scale (LAPASS) (Nentwich, 2016), which help the emergency providers assess
severity and type of stroke. The information gained during this critical time can influence
where the ambulance crew rushes the patient for continued care. As a result of the
evaluations, the providers may be able to determine if a large vessel stroke is occurring,
then divert to facilities with the resources and staff to adequately treat this type of stroke.
Once the ambulance arrives at the emergency department, the patient is immediately
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received for further assessment and care. It is important to note, those patients that do not
arrive by ambulance may have treatment delayed due to normal Emergency Department
wait times depending on number of patients already present in the department. Patient
assessment in the emergency department centers around the rapid identification of those
individuals having a vascular event. The assessment includes a rapid evaluation by an
Emergency Medicine Physician (less than 10 minutes upon ED arrival) of anyone
suspected of having a stroke. A thorough history including last known well time, age,
types of symptoms, medications (specifically antiplatelet agents, warfarin, novel oral
anticoagulants) and past medical history (CAD, HTN, DM, TIA/CVA, PVD, seizure,
tobacco or illicit drug use) is obtained. Additionally, a detailed exam of visual fields,
extraocular muscles, speech impairment, weakness or sensory deficits, incoordination,
ataxia is performed.
Additionally, physical examination determines if basic life functions are
satisfactory. If not, for example, a patient may require intubation secure the airway
ensuring oxygen saturation. Upon reaching a state of stabilization, vital signs are assessed
and neurological deficits are monitored.
The assessment tool often completed at this stage is the National Institutes of
Health Stroke Scale (NIHSS). This tool looks for patient performance in areas ranging
from “level of consciousness, language, neglect, visual-field loss, extraocular
movements, motor strength, ataxia, dysarthria, and sensory loss” (Nentwich, 2016).
Based on the clinician’s findings, the patient is rated on a scale of 0-42. A score of less
than 5 equates to a minor stroke, while a score greater than 20 signifies a severe stroke.
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In efforts to determine the cause of visible symptoms, medical staff rely on
imaging studies. First, a noncontrast computerized tomography (NCCT) study is
completed to determine if a hemorrhage exists. Identifying a possible hemorrhagic stroke
is necessary because administering t-PA for an ischemic stroke during a hemorrhagic
stroke can result in patient death. Often an NCCT is the only radiological study
completed before a patient is treated for an ischemic stroke. However, other variants of
CT scans may be used to gather greater details of the characteristics of the stroke,
including both CT with angiography (CTA) and CT perfusion (CTP). A CTA helps
determine intra- or extra-cranial arterial circulation for blockages or hardening of the
vessels. A CTP provides information on blood volume, blood flow, and transit time for
blood to perfuse throughout the brain (Nentwich, 2016). Lastly, an MRI will help
determine the type of stroke and the prognosis. Determination of prognosis is based on
the details provided on extent of damage and location of the brain affected (Nentwich,
2016). A diagnosis is reached based on information from multiple sources, including
those with the patient at the time of the stroke, EMS, as well as hospital staff.
Treatments of Acute Ischemic Stroke:
Clinicians have known for decades reperfusion was essential to treat ischemic
strokes successfully.
Initial studies in the 1950s used streptokinase and urokinase, isolated from
Streptococcus strains and human urine, respectively. Intracerebral hemorrhage
(ICH) was a leading cause of death in these early investigations, which preceded
computed tomography (CT) technology. In the 1960s, Meyer and colleagues used

12
diagnostic angiography to perform investigations, first comparing intravenous
(IV) plasmin with placebo, then combination therapy with streptokinase and
heparin versus heparin alone. Although the former showed no benefit in the
plasmin treated group, the latter showed greater mortality and ICH in the
streptokinase-treated group. The MAST-E (Multicenter Acute Stroke TrialEurope) and MAST-I (Multicenter Acute Stroke Trial-Italy) trials of streptokinase
in the 1990s further confirmed increased risk of ICH and mortality, leading to the
eventual abandonment of it as a treatment for [Acute Ischemic Stroke] AIS
(Nentwich, 2016, “Reperfusion with Intravenous Thrombolysis,” para. 1).
In 1996 the FDA approved treatment for ischemic stroke using Tissue
Plasminogen Activator (t-PA) for revascularization. T-PA is administered intravenous
into the patient’s body. The medication’s purpose is to reach the thrombus and dissolve
the clot, allowing blood to resume flow through the brain, supplying needed oxygen and
nutrients to the affected areas of the brain.
While this drug has achieved great success in preventing death and disability,
there are guidelines that must be met which dictate its use. The patient must have suffered
from a non-hemorrhagic stroke, and this determination must have occurred within 3-4.5
hours after the first observed symptoms of stroke (Stroke Foundation, 2017).
An optional adjunctive treatment to t-PA administration is mechanical
thrombectomy. In a mechanical thrombectomy, a physician will attempt to remove the
blockage by use of a stent retriever. This procedure is only completed after t-PA has been
administered and no more than six hours post onset of symptoms (ASA, 2016). In this
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procedure, the device is threaded through vessels to reach the clot. Once the clot is
reached the device will open allowing the clot to be captured, removing the thrombus
from the vessel (ASA, 2016).
Barriers to t-PA Administration:
The following can prevent stroke sufferers from receiving t-PA: lack of the
public’s knowledge of stroke identification, lack of inadequately trained, and prepared
clinicians, lack of infrastructure to support telestroke, and physician licensure
requirements. Given the lifesaving and disability preventing abilities of this drug,
clinicians should be more open to administer t-PA to as many Ischemic stroke sufferers
that meet the guidelines. However, only 3-5% of AIS patients receive t-PA (Silva &
Schwamm, 2012).
The first barrier is the lack of public awareness in identifying the symptoms of
stroke. The most commonly known symptoms of stroke are facial droop, slurred speech,
arm and leg weakness, but often these items while observed or experienced are not taken
seriously. Many patients or family members will wait to seek medical advice for various
reasons including waiting to see if the symptoms will resolve, not understanding the
severity of the situation, or preferring to contacting their PCP (Eissa, Krass, & Bajorek,
2012). This lack of action leads to many patients delaying their treatment, if they seek
treatment at all. In fact, less than 20% of AIS victims arrive at a hospital within three
hours of symptom onset (Eissa, Krass, & Bajorek, 2012). The main reason for this missed
or ignored recognition of symptoms is simply the lack of public knowledge. If the public
was widely familiar with the signs of stroke onset, proper action could occur, preventing
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late arrival to the ED, which reduces clinicians opportunity to treat patients with t-PA.
EMS education surrounding stroke may be a barrier for many reasons. When an
ambulance is called for a potential stroke patient, first responders may not be equipped
with the proper knowledge to identify a stroke, nor gauge its severity. EMS staff may not
be aware of the screening tools available to assess stroke patients under their care. In fact,
28% of stroke patients are not identified while in the care of paramedics due to the lack
of EMS knowledge (Eissa, Krass, & Bajorek, 2012). Additionally, first responders may
transport the patient to the nearest hospital instead of a facility properly equipped for
thrombolysis. As an example of this occurrence, a study in Switzerland found that 20% of
stroke patients were transported to hospitals that do not administer t-PA (Eissa, Krass, &
Bajorek, 2012). Patients transferred to facilities that lack thrombolysis services will only
have an opportunity to receive t-PA if they are later transferred to a facility that
administers t-PA, yet subsequent transfers only reduce the already short window for t-PA
administration.
First responders and paramedics are not the only health care professionals that are
lacking in preparedness to properly care for stroke patients. As one can imagine, not all
patients will arrive via ambulance. Those patients who arrive by other methods will enter
the ED and will process through triage. Previous studies have found opportunities for
improvement exists during this phase of care. If the nurses are not adequately educated to
identify a stroke rapidly and accurately, further delay in care can result (Eissa, Krass, &
Bajorek, 2012). After triage for a suspected stroke, a protocol or code should be initiated.
Some EDs do not have efficient workflows, inhibiting the execution of a stroke protocol.
It is crucial these protocols be established and well rehearsed. These workflows should
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ensure that necessary diagnostics and staff notification occur. As important as the
protocols are, the staff caring for stroke patients need to be educated on best practices in
caring for a stroke patient.
Most clinicians are knowledgeable and professional. However, institutions that
may not see a high number of stroke cases will need to remain up-to-date on clinical
practices. Additionally, some providers are hesitant to administer t-PA because they lack
familiarity with the drug or have had unwanted results from a past case. One study
investigating barriers to using thrombolysis found 40% of 2,600 emergency medical
physicians are unlikely to use t-PA, even under ideal conditions (Eissa, Krass, & Bajorek,
2012). The researchers also reports the result of a survey conducted in Los Angeles,
"60% recognized that thrombolysis should be administered within 3 hours, and 28%
indicated that they did not even consider the use of thrombolysis in AIS” (Eissa, Krass, &
Bajorek, 2012). It is important to point out that emergency medical providers create most
emergency departments' policy and procedures. If these providers are uncomfortable with
or knowledgeable about proper utilization of t-PA, policies will reflect this same
confusion (Eissa, Krass, & Bajorek, 2012). In light of this type of preparedness/practices
emergency departments moving towards nontraditional stroke treatment models. Some
health care institutions are moving away from on-site clinicians for reasons stated
previously. The nontraditional models being migrated to are based on technology that
bridges the gaps identified in the previous paragraph. This move utilizes technology and
is called telestroke, a form of telehealth.
Telehealth, however also has its barriers to functionality, installation, and
implementation. Telestroke is defined as,
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“Telemedicine involves the use of videoconferencing, which incorporates a
dedicated, high-quality, interactive, bidirectional audiovisual system, alongside
the use of teleradiology that enables the remote inspection of brain scans. This
system allows the bedside and distant (expert neurologist) clinicians to clearly see
and hear each other in full colour via the use of appropriate cameras and display
screens” (Eissa, Krass, & Bajorek, 2012).
The barriers that often exist with telestroke include the following: lack of a reliable and
fast internet connection, expensive audio/video conferencing equipment, insufficiently
trained staff, and insufficient funds to implement and maintain this solution (Eissa, Krass,
& Bajorek, 2012). Through telestroke a neurologist can assist the care team on-site from
a remote location. There is no real limitation on distance from the remote provider to the
patient and the on-site care team. However, because telestroke care allows for care
remotely, from anywhere in the world, legal barriers often arise.
Because providers are often licensed to practice in one state, out-of-state
consultation and referrals can be a challenge when licensure is considered. Much can be
learned from teleradiology, which is responsible for 50% of all telemedicine that occurs
in the United States. For example, some states are offering special telemedicine licenses
for radiologists, and some physicians who practice outside of the states that allow a
special license are seeking licensure in all 50 states. In addition to state licensure
presenting a potential barrier, hospital credentialing is also a concern. Typically,
physicians need to have credentials in the hospitals where they practice, yet this can be
difficult, time-consuming, expensive, and redundant. However, in 2011 CMS made this
process easier "by allowing hospitals to rely on the credentialing and the privileging
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decision of the distant hospital where the consulting physician practices" (Weinstein et
al., 2014). Each of the barriers that can slow or even prevent the administration of t-PA
need to be resolved to increase the currently low utilization rate of t-PA.
Telestroke:
Although telestroke can present itself as a barrier, telestroke can also be used to
correct gaps in stroke care to be corrected by its capability. Telemedicine, according to
the American Heart Association, is "the use of telecommunication technologies to
provide medical information and services" (Perednia & Allen, 1995). This definition is a
vague but accurate definition of telemedicine because it does not focus on one device or
technology. The history of telemedicine use ranges from telephones and fax machines to
two-way video and audio conferencing between a patient and an off-site provider. As
long as an electronic medium is used to transmit medical information, it is classified as
telemedicine. (Demaerschalk et al., 2009). This exchange of data has existed in some
form since the early 1900s. During this time the ability existed to transfer
electrocardiograms and electroencephalograms through analog telephone lines. In the
1920's, medical advice and information was transferred by the use of Morse code and
two-way radios. It was not until the 1960's, however, that the medical profession was able
to transmit information using methods similar to those used today. Currently, with the
advances in technology, personal computing devices, and the Internet, patients and
providers are now able to communicate with one another on opposite sides of the globe,
if needed. As one can imagine, telemedicine can be applied in many different practices.
Some of the areas that this technology is used include “dermatology, oncology, outpatient burn victims follow-up, radiology, cardiology, psychiatry, emergency medical
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services, rural medicine, nephrology, urology, emergency department, home health”
(Duchesne et al., 2008), and stroke.
Just as there are many uses of telehealth as detailed above, there are many settings
in which telestroke is utilized. One common schema of stroke telehealth is referred to as
“hub and spoke." This system is made up of a centralized location, the hub, and satellite
facilities in areas lacking appropriate staff and resources, the spokes. The hubs are located
in metropolitan areas while the spokes are in rural or underserved areas. (Demaerschalk
et al., 2009) The components used in these systems are typically "high-resolution digital
camera, microphone, speaker, a server for scan storage, and a monitor for the patient to
view the telestroke practitioner” (Demaechalk et al., 2009). To better illustrate the use of
telehealth in stroke, a case example is provided below.
A 75-year-old female resident of a rural community identified the sudden
onset of left facial droop, slurred speech, and weakness and numbness of the left
arm and leg at 3:30 PM. She presented to the local emergency department of the
spoke hospital at 4:21 PM, at which time the emergency department physician
examined her and initiated a stroke alert. Blood samples were drawn, CT was
completed, and the spoke center activated the telestroke hub hotline. The hub
center’s on-call stroke neurologist responded. After the patient had undergone CT,
the telestroke camera system was placed in front of the patient and the
consultation began at 5:08 PM. The patient and her family interacted with the
stroke neurologist via the camera system, answered questions, and engaged in the
consultation. The spoke emergency department nurse assisted the stroke
neurologist with the examination and the laboratory results. The stroke
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neurologist zoomed in on the cardiac monitor to observe the patient’s
electrocardiographic results, heart rate, blood pressure, respiratory rate, and
oxygen saturations. During the AV telemedicine examination, the stroke
neurologist simultaneously accessed the CT by a Digital Imaging and
Communications in Medicine system. Through examination via the AV camera
system, the NIH Stroke Scale score was determined to be 6. After the clinical,
laboratory, and CT examinations were complete, the neurologist requested the
presence of the emergency physician and the daughter at the bedside to discuss
the plan for care. At 5:53 PM the stroke neurologist reviewed the observations
and recommended the administration of t-PA. The spoke emergency department
initiated t-PA at 6:09 PM. The hub stroke neurologist dictated a consultation and
faxed it to the spoke center emergency department. (Demaerschalk et al., 2009)
In addition to telestroke practice in the above manner, delivery of care without
allowing geography to act as a barrier is a possibility. Consistent with telestroke
advances, health care is seeing a treatment technique for stroke called "drip and ship."
This technique is utilized when a patient presents to a satellite facility, sometimes a rural
hospital lacking specialized physicians, and the patient is evaluated and found to have
stroke symptoms. The patient is administered t-PA (drip), and after administration and
stabilization, is transferred to a medical hub for further treatment and evaluation (Pervez
et al., 2009).
The Cost of Telestroke:
Although it can be a lifesaving technological enhancement when applied in the
appropriate circumstance, the implementation of telestroke is not without its drawbacks.
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In fact, this offering to the community is very expensive. In the hub and spoke model
described above, it is not uncommon for a spoke on average to spend $46,000 annually,
while the possible figure can range from $10,000 to $200,000 (Demaerschalk, 2010).
Factors that would affect this annual cost are the type of facility, utilization rates of the
telestroke service, hardware and software selection, case complexity, and follow-up
needs. Additionally, post-installation of the technology maintenance fees for hardware
and software also add to the total cost. The funds required to support and sustain this
technology are difficult to obtain. Many telestroke programs are dependent on public
funding in the form of grants or subsidies (Demaerschalk, 2010). In recent years,
telestroke and other telemedicine programs have realized more public and private
insurance reimbursement, but more revenue sources are needed to enable widelyavailable telestroke access.
Reimbursement of Telestroke:
Medicare is the insurer that is responsible for the greatest number of stroke
patients in the US, paying for an estimated 72% of strokes (Bonilha et al., 2014). Because
of that overwhelming percentage, Medicare is consulted for guidance regarding future
reimbursement for telehealth and telestroke services.
Currently, there are some Medicare reimbursement requirements Medicare. The
main requirement is the originating site clause, which “is the location of an eligible
Medicare beneficiary at the time the service is furnished via a telecommunication
system" (DHHS, 2015). Furthermore, Medicare patients must also be at an originating
site in a "rural Health Professional Shortage Area (HPSA) located either outside a
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Metropolitan Statistical Area (MSA) or in a rural census tract; or a county outside of a
MSA" (DHHS, 2015). The DHHS also describes the technological functionality required:
the patient must receive audio and visual telecommunication that fosters real-time
communication between the remote provider and the patient (DHHS, 2015). In some
circumstances asynchronous or “store and forward” is permitted but only in specific
programs (DHHS, 2015).
Medicaid has a greater variance in regulation than Medicare, which are largely
based on the respective state's ability to define what is covered by the state’s plan. In
2013, 42 states included some telemedicine services in their plans. The amount of
coverage varies considerably. California, for instance, has no limiting guideline
preventing telehealth services based on geographic area, while other states follow a
Medicare-like approach, permitting services only in rural localities (Horton, Malcarney,
& Seiler, 2014).
Other payers besides Medicare are beginning to offer reimbursement for
telemedicine, but there has not been an universally recognized insurance policy to this
point. Some states have required insurers to pay for these services while privately insured
plans are not included in these laws. In 2013, 16 states required insurance agencies to pay
for telehealth services. However, many of these state laws are not following Medicare’s
approach to underserved areas. In fact, Maryland prohibits any insurer from
distinguishing between rural and non-rural areas (Horton, Malcarney, & Seiler, 2014).
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Cost Attributable to Rehab Care:
Stroke disables more people than any other medical condition in the United
States. As a result of stroke’s high incidence and often-debilitating effect on its sufferers,
it costs the nation greatly. In fact, the net present value per admission into a nursing home
as a result of a stroke is $29,296 (Taylor et al., 1996). Additionally, the mean lifetime
cost for ischemic stroke suffers was estimated to be $123,565 per person (Taylor, Davis,
Torner, Holmes, Meyer, & Jacobson, 1996). Two resulting disorders caused by stroke
that often cause people to seek rehabilitation care are aphasia and dysphagia.
Aphasia is a speech disorder that affects around 100,000 stroke survivors annually (Ellis,
Simpson, Bonilha, Mauldin, & Simpson, 2012). The disorder leaves the patient with an
impaired ability to communicate. The difficulties caused by this disorder result in greater
need for medical resource utilization, as well as greater morbidity and mortality. Clearly,
greater resources are needed to care for these patients, otherwise increased rates of
medical complications will increase the cost of caring for these patients. It has been
estimated that the increase in medical expenditures is $1,703 for stroke patients with
aphasia, versus a patient who does not experience aphasia post-stroke. Further, an
increase in the length of stay (LOS) has been determined to increase costs by 6.5% (Ellis,
Simpson, Bonilha, Mauldin, & Simpson, 2012).
Dysphagia is also a common post-stroke condition. The difficulty of swallowing
characterizes this medical condition. This condition is common for stroke patients,
occurring in 37-78% of stroke patients (Bonilha et al., 2014). Dysphagia is also known to
cause a need for a higher level of medical treatment and expenditures in stroke patients
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that encounter this disorder compared to those that do not (Bonilha et al., 2014). The
comorbidities of this disorder include dehydration, worse long-term outcomes, and
increased risk of aspiration pneumonia (an infection in the lungs resulting from inhaling
food or liquid into the lungs). The article titled, The One-Year Attributable Cost of PostStroke Dysphagia, reported that 64% of stroke patients that require inpatient
rehabilitation care suffer from varying degrees of dysphagia. Just as aphasia has a higher
financial cost to treat, so does dysphagia. This disorder is said to cost $4,510 more to
treat when present (Bonilha et al., 2014). The increased cost is associated with increased
need for hospital resources utilization, discharge to a skilled nursing facility, and extra
durable medical equipment. On average, dysphagia increases stroke health care costs by
23% and results in a 30% increase in length of stay (Bonilha et al., 2014).
Aphasia and Dysphagia are costly, both financially and medically. Having one or
both of these conditions will cause impairment and increase the costs of care for both the
insurer and the patient. It is important to note that Medicare is the insurer for 72% of all
stroke patients, meaning the United States and its taxpayers fund the majority of stroke
care (Bonilha et al., 2014). Knowing how impactful stroke is medically and financially to
the survivors and the nation, anything that can be done to improve stroke outcomes
should be pursued.
Underutilization of t-PA:
T-PA is a pharmaceutical that can have a great impact on a patient suffering from
a stroke if administered within the 3-4.5 hour window. Patients who experience a better
outcome are those that receive the drug with the least amount of time having elapsed
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between onset of symptoms and administration of t-PA. Between these two points many
factors that can contribute to delay prolonging or prevent administration. Many of these
factors were discussed in the Barriers section of this work. However, additional factors
are relevant and contribute to the utilization of t-PA. In the United States, there are
Primary Stroke Centers (PSC) and Comprehensive Stroke Centers (CSC). These facilities
possess properly trained staff, streamlined workflows, and the necessary facilities and
equipment to treat stroke patients. While these types of facilities are well prepared to deal
with stroke patients, they do not represent the majority of acute care medical facilities
(Demaerschalk, 2010). The majority of PSCs and CSCs are located in metropolitan areas,
while 40% of the United States population lives in the countryside. This disparity does
not augur well for those that live outside the immediate service areas of these specially
designated facilities.
In addition to lack of properly equipped facilities, many other variables contribute
to the low administration rate of t-PA to acute ischemic stroke patients. These variables
include the lack of timely identification of stroke symptoms, delays in reaching a medical
facility, unavailability of properly prepared medical staff, misdiagnosis of stroke, and the
short t-PA administration window. An investigation is needed to uncover additional
information that describes low utilization. Uncovering this information will empower the
medical systems to save greater lives and reduce the rates of disability.
Utilization of t-PA in South Carolina:
Traditionally, states in the South and Midwest have had the lowest rates for t-PA
administration (Samson, Trivedi, & Heidari, 2015). These low rates are believed to be the
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result of a lack of accessibility to t-PA prepared facilities (Samson, Trivedi, & Heidari,
2015). The distance between patient residence and medical facilities causes the
inaccessibility. In 2013, around one-half of South Carolina’s citizens lived within 30
minutes of a stroke center, and 30% lived within 60 minutes. Increased time and distance
from stroke centers further delays evaluation, diagnosis, and treatment. South Carolina
and other areas that share this characteristic will see greater mortality and disability of
their stroke patients. A study titled, “Telestroke Centers as an Option for Addressing
Geographical Disparities in Access to Stroke Care in South Carolina, 2013”, found that
counties in South Carolina without a PSC within 30-60 minutes are found to have higher
death rates than South Carolina counties that do have a PSC within 30-60 minutes (2015).
The authors of this study also reasoned that if telestroke equipped facilities were more
prevalent, the rate of mortality could decrease. The two charts below provide references
of population per county in South Carolina and counties that have telestroke-equipped
facilities. As reflected in the charts, many counties are without a telestroke prepared
facility.
2010 Census by County
Figure 1
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Data retrieved 19Feb2017
U.S. Census Bureau: 2010 Census
Figure 2
Telestroke Facilities by County in 2013
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Figure 3
Number of Telestroke Sites per County in 2013
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The majority of PSC facilities in South Carolina are located in the northwestern
part of the state and in the coastal region near Charleston. When the telestroke facilities
are factored into available destinations for stroke care, 76% of the population lives within
30 minutes, and 95% are within 60 minutes (Samson, Trivedi, & Heidari, 2015). South
Carolina has a few telestroke networks that enable stroke services in more facilities than
just the PCSs. One network in particular is called REACH-MUSC, which stands for
remote evaluation of acute ischemic stroke at Medical University of South Carolina.
REACH-MUSC is a hub and spoke model, with MUSC’s main tertiary facility serving as
the hub. The hub provides remote access to neurologists, emergency department
physician with acute stroke experience, neurointerventionalists, neurointensivists, and
neurosurgeons as members of an integrated team. MUSC’s team is available 24 hours a
day, seven days a week, and 365 days a year. The clinicians at MUSC’s hub provide
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services to 12 spoke facilities, ranging in size from 25 to 453 beds with the furthest spoke
being 187 miles away (Lazaridis, DeSantis, Jauch, & Adams, 2013).
REACH-MUSC operates in the following manner. When a patient arrives at a
spoke member of the network, the MUSC Emergency Communication Center (MECC) is
called, and the specialists are alerted. The on-call providers enter the REACH website
utilizing all connected technology to assist in the assessment and evaluation of the
patient. Based on the work-up, a joint decision is made to administer t-PA or not
administer the agent (Lazaridis, DeSantis, Jauch, & Adams, 2013). In the article,
“Telestroke in South Carolina,” it is reported the REACH-MUSC experienced a 35.7% tPA administration rate out of a total population of 965 consults. Out of the total
population in the study, 525 members of the population had a NIHSS score greater than 3
(Lazaridis, DeSantis, Jauch, & Adams, 2013). South Carolina witnessed a much higher
administration rate of the life-saving drug, t-PA when only including participants of
REACH-MUSC. The main difference between investigating utilization in only PSC
(single facility) compared to a hub and spoke network model is telestroke services are
more available (Lazaridis, DeSantis, Jauch, & Adams, 2013).
Following Research:
The possible linkage to greater accessibility and higher rates of t-PA
administration when stroke victims reside closer to facilities equipped with telestroke
requires study. Using the Healthcare Cost and Utilization Project (HCUP) State Inpatient
Database (SID) to identify patients with ICD-9-CM codes of 434.xx (AIS) and if they
live in a South Carolina county offering stroke services will be conducted. The goal of
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this effort is to determine if patients are more likely to receive t-PA if it is available in
their home county. If higher rates of t-PA utilization in counties that offer necessary
stroke services are found, this evidence can be provided to hospital administrators and
legislators with the goal of increasing the number of counties offering telestroke services.
Currently, many barriers that contribute to underutilization are known, but more research
is necessary to determine any additional factors.
Hypothesis:
In the state of South Carolina, patients who suffer an ischemic stroke in counties
that contain medical facilities offering telestroke services are more likely to receive t-PA
compared to patients who live in counties that do not have telestroke services.
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CHAPTER 3: METHODS
The data used to test the hypothesis originates from the Healthcare Cost and Utilization
Project (HCUP) South Carolina State Inpatient Database (SID). HCUP is a data source
populated from many databases ranging from various state–based organizations,
hospitals, private, and Federal government databases. The data contained within HCUP
consists of encounter-level, inpatient data. The SID data “encompass all patients,
regardless of payer, providing a unique view of inpatient care in a defined market”
(AHRQ, 2016).
Utilizing the HCUP South Carolina SID two cohorts are defined. The cohorts
were defined as "Telestroke Access" and "No Telestroke Access." These cohorts shared
the commonality of primary diagnosis of Acute Ischemic Stroke (AIS) and were and
were not administered t-PA during an encounter. The “telestroke access” cohort was
defined as patients who live in a SC county that offers telestroke services. While the “no
telestroke access” cohort included patients who do not live in a county where the
hospitals offer telestroke services.
The data used for this study were obtained from the South Carolina State office of
Research and Statistics (ORS) and includes all hospital discharge billing records for all
South Carolina hospitals in 2013. Because of the de-identifiable nature of the data, it has
been deemed non-human research and does not require review by the MUSC Institutional
Review Board.
Study Design and Population:
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This study is a retrospective observational cross-sectional analysis using
secondary data from the year 2013. The population in this study was defined as patients
with a primary diagnosis of ischemic stroke, 434.x or 436.x, based on accepted coding
standards using the International Classification of Diseases 9th Revision – Clinical
Modification (ICD-9-CM) (Reker, Hamilton, Duncan, Yeh, & Rosen, 2001).
Additionally, comorbidity and patient demographics were evaluated and controlled for in
both patient populations. Comorbidity was accounted for by the use of the Deyo version
of the Charlson Comorbidity Index (CCI). CCI was developed to use administrative data
to establish a risk-adjusted index, measuring the probability of death within one year
(Simpson, A. et al., 2015). The CCI provides researchers the ability to extrapolate the
index by processing patients’ ICD diagnoses data producing corresponding weighted
values (Simpson, A. et al., 2015). In addition to CCI, the Stroke Severity Score (SSI) was
utilized. SASI was created to predict the outcome of stroke patients based on stroke
severity from data gathered from the NIHSS. Comparison groups were selected by
splitting the population into cohort “Telestroke Access” and “No Telestroke Access”
based on whether a hospital has submitted at least two bills for telestroke consultations in
that year. These codes are provided by the Healthcare Common Procedure Coding
System (HCPCS) Level II and are G0425, G0426, G0427 (DHHS, 2015). The existence
of these codes designates that a patient has received telehealth consultation either in an
emergency department or an inpatient setting for specified amounts of time (CMS, 2016).
Statistical Analysis:
The study’s data was evaluated using multivariable regression. The control and
predictor variables variable are listed below. Non-control variables are the existence of
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telestroke services and administration of t-PA. There is a limited need to control for
demographic variables since the data consists of all stroke encounters in South Carolina
during the 2013 calendar year. However, comorbidities were controlled for using CCI
and SASI. During the initial phase of statistical analysis, descriptive measures of central
tendency and variability were completed. In completing these measurements, mean and
standard deviation were calculated for each of the variables. When assessing the
distribution of the categorical variables, percentages and frequencies were calculated for
all categorical data elements. Then the comparison populations were evaluated (patients
living in counties with access to telestroke hospitals and those not living in counties
having telestroke). Descriptive statistics were performed to examine differences in
demographic and patient characteristics between the two groups at baseline using chisquare tests for categorical data, t-tests for normally distributed continuous variables, and
the Wilcoxon/Mann-Whitney U test for non-normally distributed continuous variables.
Adjusted analysis was conducted using multivariable logistic regression models, giving
the odds of t-PA administration between the two groups using adjusted odds ratios. All
covariates listed in the descriptive statistics were assessed in the multivariable model.
Traditional model-fitting procedures (log-rank tests and Akaike Information Criterion)
were used to assess the value of each independent variable in the model (Hosmer &
Lemeshow, 2000). Variables were removed from the model if they are not statistically
significant (P-value > 0.5) and their removal does not reduce model strength until a final
parsimonious bet fit model was found.
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CHAPTER 4: MANUSCRIPT
The South Carolina Telestroke Program:
Does County-level Telestroke Access Increase the Odds that Patients Will Receive t-PA?
Introduction:
Stroke is a disease that is responsible for causing more disability to its victims
than any other disease (Silva & Schwamm, 2012). In the United States alone, 780,000
strokes occur annually. In 2014, it was the cause of death in 1 in 16 people. (Kazley,
Simpson, K., Simpson, A., Jauch, & Adams, 2013). Although there are many different
types of stroke, the type with the highest rate of occurrence is ischemic, comprising 87%
of all strokes. (Demaerschalk, Hwang, & Leung, 2010). This type of stroke is responsible
for a large burden on society with; 30% of those who survive become permanently
disabled, and 20% require inpatient care for three-months post event. Not only is this
costly for the patient, but also costly on society. In 2008, indirect and direct costs
associated with stroke totaled $65.5 billion dollars (Demaerschalk, Hwang, & Leung,
2010). The amount cited above is important, because the majority of people who suffer a
stroke have their health care financed by the American taxpayer through Medicare
(Bonilha et al., 2011).
In 1996, the FDA approved a revolutionary treatment for stroke a named
pharmaceutical called Tissue Plasminogen Activator (t-PA), which works to dissolve the
clot in the patient’s vessel inside the brain. T-PA has been used with great success over
the years, but due to its strict indications for use, only 3-5% of stroke patients receive tPA in the United States. The stroke patients that have received t-PA have experienced
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better outcomes compared to not receiving the thrombolysis. However, many stroke
patients throughout the country are not realizing the benefits of this life-saving/disability
preventing treatment. There are many reasons that prevent or impede administration of tPA, however, the one of focus in this work is proximity to facilities prepared for ischemic
stroke patients. It is believed, if patients experiencing an ischemic stroke live in a county
having access to properly prepared clinical staff and resources to diagnosis and treat
ischemic stroke, they will have a greater chance of receiving the brain cell saving drug, tPA. In research of this hypothesis, a 2013 sample of stroke patients from South Carolina
will be analyzed. The data will be reviewed to uncover if stroke patients’ county
(“Telestroke Access”) of residence had necessary stroke treatment resources and if these
patients realized greater rates of t-PA administration compared to stroke patients living in
counties (“No Telestroke Access”) not offering the same resources.
Background:
“Time is Brain” is a phrase used throughout the medical world in reference to
stroke. The meaning of this three-word phase is, for every minute of oxygen loss to the
brain two million brain cells die (Morrissey, 2013). This fact is the result of starving
brain tissue of oxygen past an occlusion in a brain vessel. When this occurs the blockage
prevents the flow of oxygen carrying blood to those areas of the brain beyond the
occluded vessel. The goal of treating a ischemic stroke patient is to restore blood flow as
quickly as possible limiting the amount of brain cell death.
T-PA is a thrombolytic that when used dissolves the blockage and restores blood
flow to the brain. The difficulty experienced with the administration of this drug is the
many barriers that prevent its use. First and foremost, t-PA has a short window in which
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it can be administered. As specified by the FDA it can only be administered within 3 –
4.5 hours post onset of stroke symptoms. There are many other impediments that play a
role in delaying administration, these are: travel time from site of stroke onset to medical
facility, preparedness of EMS staff (if their services are utilized), time between entering
an emergency department lobby to triage to being seen, the readiness of emergency
departments to care for ischemic stroke patients, is the staff properly trained and do they
have specially trained neurologist or emergency medical physicians available, assessment
of symptoms, diagnosis of ischemic stroke (making sure to role out hemorrhagic stroke),
and finally, decisions to administration t-PA. It is important to note that not all medical
facilities receiving ischemic stroke patients have t-PA available for administration. The
availability of having access to properly trained staff and physicians cannot be
understated. It has been stated, some providers are hesitant to administer t-PA because of
they lack familiarity with the drug or have had negative results from a past case. One
study investigating barriers to using thrombolysis found 40% of 2,600 emergency
medical physicians are unlikely to use t-PA, even under ideal conditions (Eissa, Krass, &
Bajorek, 2012). The researchers also reports the result of a survey conducted in Los
Angeles, "60% recognized that thrombolysis should be administered within 3 hours, and
28% indicated that they did not even consider the use of thrombolysis in AIS” (Eissa,
Krass, & Bajorek, 2012). The above article describes the importance of having access to
properly prepared providers in the instance of ischemic stroke patients. Furthermmore,
the lack of specially trained providers in a facility receiving stroke patients has been
shown to lower the likelihood of t-PA administration (Silva & Schwamm, 2012). Of the
barriers listed preventing administration of t-PA to qualifying stroke patients of most
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importance in this research is the availability of stroke specialists. For safe an effective
administration of t-PA these providers should be member of a stroke patient’s care team.
When they are not, as stated above, patients are less likely to be administered t-PA. Many
smaller medical facilities, especially those located in less densely populated, southern and
mid-western regions of the United States do not have the stroke specialist on staff or
available 24/7 (Samson, Trivedi, & Heidari, 2015). In the instances methodologies can be
implemented to reduce the disparities of care.
Telestroke:
Telestroke defined by the American Heart Association (AHA), is “the use of
telecommunication technologies to provide medical information and services” (Perednia
& Allen, 1995). In providing more detail to AHA definition, telestroke occurs when a
stroke patient presents to a medical facility that does not have the needed stroke clinicians
available but instead is a member of a telestroke network. One common schema is the
“hub and spoke” model. This system is made up of a centralized location, the hub, and
satellite facilities in areas lacking appropriate staff and resources, the spokes. The hubs
are located in metropolitan areas while the spokes are in rural or underserved areas.
(Demaerschalk et al., 2009). The components used in these systems are typically "highresolution digital camera, microphone, speaker, a server for scan storage, and a monitor
for the patient to view the telestroke practitioner” (Demaechalk et al., 2009). During the
telestroke encounter many gaps in care are eliminated and the specialist at the hub can
assist the clinicians at the spoke in diagnosing and providing the proper level of care for
the patient based on assessment, diagnostic test results, and properly informing the
patient and family members of treatment methodology. Once all of the above is
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completed the stakeholders collectively proceed with administration of t-PA when
warranted. The belief of this research is, patients whom live near a facility that is
equipped with telestroke or these specialized providers patients will be more likely to
receive t-PA.
South Carolina:
In 2013, around one-half of South Carolina’s citizens lived within 30 minutes of a
stroke center, and 30% lived within 60-minutes. Increased time and distance from stroke
centers further delays evaluation, diagnosis, and treatment, South Carolina and other
areas that share this characteristic will see greater mortality and disability of their stroke
patients. A study titled, “Telestroke Centers as an Option for Addressing Geographical
Disparities in Access to Stroke Care in South Carolina, 2013”, found that counties in
South Carolina without a PSC within 30-60 minutes are found to have higher death rates
than South Carolina counties that do have a PSC with 30-60 minutes (2015). The authors
of this study also reasoned that if telestroke equipped facilities were more prevalent, the
rate of mortality would decrease. In this study, proximity to telestroke facility is based on
if the patient resides in a county designated as “Telestroke Access”. South Carolina’s
“Telestroke Access” counties can be referenced in Figure 1. In Figure1 the colored
counties have access to telestroke resources. The counties designated with a large star are
those that possess a hub, all others are considered spokes. There are vast regions of the
state do not have “Telestroke Access” and are considered “No Telestroke Access”. Figure
2 displays county population data based on the 2010 U.S. Census. This figure shows the
relation of population density of counties throughout the state. When one compares
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Figure 1 to Figure 2 the comparison further proves counties with lower density are less
likely to have telestroke access.
Telestroke Facilities by County in 2013
Figure. 1

Date Retrieved 8Jan2017
http://palmettocareconnections.org/telehealth-in-sc/telehealth-services-map/
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2010 Census by County
Figure. 2

Data retrieved 19Feb2017
U.S. Census Bureau: 2010 Census
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Methods:
Database and Study Population:
Data used in this study was obtained from the Healthcare Cost and Utilization
Project (HCUP) South Carolina State Inpatient Database (SID). The data collected in this
dataset originates from various state-based organizations, hospitals, private, and Federal
government databases. The data contained within HCUP consists of encounter-level,
inpatient data. This study was completed using data from 9,311 patients with a primary
ICD-9-CM diagnosis of stroke (424.xx & 436.xx). The primary diagnosis is assigned to
patients post discharge from the hospital based on clinical information gained during
patients’ encounter(s). ICD-9 codes are used throughout the world for the purpose of
statistics gathering and tracking mortality and morbidity. ICD-9 codes are published and
updated by the World Health Organization. Additionally, ICD-9 code of 99.10 was used
to determine if the patient had received t-PA.
The study was then broken into two cohorts. Each cohort was defined based
patients’ county of residence. The counties of South Carolina are defined as either
“Telestroke Access” or “No Telestroke Access.” Each county was placed into this
grouping based on data collected concerning if the county has a medical facility that had
access to telestroke services (Palmetto Care Connections, 2017).
Statistical Design:
The data used in this research was exempt from the Medical University of South
Carolina’s IRB process due to being de-identified, it is thus deemed non-human research
and does not require review. This study is a retrospective observational cross-sectional
analysis using secondary data from the year 2013. The population in this study was
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defined as patients with a primary diagnosis of ischemic stroke, 434.xx or 436.xx based
on accepted coding standards. Additionally, comorbidity and patient demographics were
evaluated and controlled for in both populations. The record was further analyzed for the
presence of the ICD-9 code of 99.10, the code assigned when a patient is administered tPA. Comorbidities was accounted for by using the Deyo version of the Charleson
Comorbidity Index (CCI). CCI was developed to use administrative data to establish a
risk-adjusted index, measuring the probability of death within one year of event
(Simpson, A. et al., 2015). The CCI provides researchers the ability to extrapolate the
index by processing patients’ ICD diagnosis data producing corresponding weighted
values (Simspon, A. et al, 2015). Additionally, severity of stroke was controlled for using
the Stroke Severity Index (SSI). SSI was created to predict the outcome of stroke patients
based on stroke severity from data gathered from the NIHSS (Simpson, A. et al., 2017).
Statistical Analysis:
The study data was evaluated using a multivariable regression. During the initial
phase of statistical analysis, descriptive measures of central tendency and variability were
completed. In completing these measurements, mean and standard deviation were
calculated for each of the variables. When assessing the distribution of the categorical
variables, percentages and frequencies will be calculated for all categorical data elements.
Then the comparison populations will be evaluated (patients living in counties with
access to telestroke hospitals and those not living in counties having telestroke).
Descriptive statistics will be performed to examine differences in demographic and
patient characteristics between the two groups using chi square tests for categorical data,
t-test for normally distributed continuous variables, and the Wilcoxon/Mann-Whitney U
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test for non-normally distributed continuous variables. Final analysis models examining
the adjusted “risk” of t-PA administration between the two groups will be reported using
adjusted odds ratios and multivariable logistic regression methods. All covariates listed in
the descriptive statistics will be assessed in the multivariable model. Traditional modelfitting procedures (log-rank tests and Akaike Information Criterion) will be used to assess
the value of each independent variable in the model (Hosmer & Lemeshow, 2000).
Variables will be removed from the model if they are not statistically significant (P-value
> 0.05) and their removal does not reduce model strength until a final parsimonious bet
fit model was found.
The formula used to represent analysis conducted in the study is:
Log odds (receipt of t-PA)= Intercept +ß1Telestroke + ß2CharlsonComobidityScore +
ß3SASIStrokeSeverityScore + ß4…10PatientDemographics
The independent variable in this study is “Telestroke Access” vs. “No Telestroke
Access”. The dependent variable is whether the patient received t-PA or not and the
control variables where age, gender, race, CCI, and SASI. The data was analyzed using
SAS statistical software version 9.4 (SAS Institute, Inc., Cary, NC).
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Table 1. Demographics and Characteristics of "Telestroke Access" vs. "No Telestroke
Access"
Overall

Telestroke Access

No Telestroke Access

(n=9,311)

(n=5,132)

(n=4,179)

Age 20-59 ^

1595 (17.13)

853 (16.62)

742 (17.76)

Age 60-74 ^

3335 (35.82)

1844 (35.93)

1491 (35.68)

Age 75+ ^

4381 (47.05)

2435 (47.45)

1946 (46.57)

Female ^

4739 (50.9)

2639 (51.42)

2100 (50.25)

0.26

Caucasian ^

5767 (61.94)

3159 (61.55)

2608 (62.41)

0.39

t-PA ^

461 (4.95)

262 (5.11)

199 (4.76)

0.36

Charlson Comorbidity Index†

1.55 (±1.71)

1.53 (±4.9)

1.57 (±1.73)

0.35

Stroke Sensitivity Index†

3.61 (±4.84)

3.73 (±4.93)

3.46 (±4.72)

<0.01

†

Mean (±SD)

^

N (%)

p-value*

0.34

*p-values were calculated to compare characteristic differences between the 2013 Telestroke Access Group and the No
†

Telestroke Access Group non-parametric Mann-Whitney/Wilcoxon Scores for continuous variables and Chi-square for
categorical variables^.

Table 2. Patients Seen in South Carolina's Telestroke Counties
County

Overall

N (%)
Richland
735 (14.32)
Greenville
711 (13.85)
Charleston
653 (12.72)
Horry
640 (12.47)
Florence
399 (7.77)
York
244 (4.75)
Georgetown
206 (4.01)
Pickens
193 (3.76)
Darlington
181 (3.53)
Greenwood
177 (3.45)
All values are expressed in N (%)

County
Kershaw
Laurens
Oconee
Dillon
Marion
Williamsburg
Newberry
Fairfield
Jasper

Overall
(n =5,132)
N (%)
170 (3.31)
164 (3.20)
146 (2.84)
115 (2.24)
98 (1.91)
96 (1.87)
96 (1.87)
67 (1.31)
41 (0.80)
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Table 3. Patients Administered t-PA in South Carolina's Telestroke Counties
County

Overall
N (%)

County

Overall
(n =5,132)
N (%)
4
4
3
3
3
2
1
1
0

Greenville
61 (8.6)
Georgetown
Charleston
54 (8.3)
Newberry*
Richland
46 (6.3)
Darlington
Horry
19 (3.0)
Oconee
Florence
16 (4.0)
Fairfield*
Pickens
15 (7.8)
Williamsburg*
Laurens
10 (6.1)
Dillon
York
8 (3.3)
Marion*
Greenwood
7 (4.0)
Jasper*
Kershaw
5 (2.9)
* Indicate less than 100 ischemic stroke patients in 2013; second column percentages removed due to small
cell sizes.

Results
Patient Characteristics and Outcomes:
According to the data presented in Table 1, 9,311 South Carolinians suffered from
an ischemic stroke in 2013. Of the 9,311 patients 55.12% (5,132) lived in counties
deemed to have telestroke access while 44.88% (4,179) lived in without telestroke access
counties. The age breakdown of the population consists 47.05% of patients being 75
years or older, 35.82% between the ages of 60-74, and 17.13% between 20-59. The
population is roughly half males (49.1%). There was a greater proportion of females that
lived in counties with telestroke access, 2,639 (51.42%) compared to 2,100 (50.25%)
without telestroke access. The race of the South Carolina’s population consists mainly of
Caucasians (61.94%) and minorities. 61.55% of the Caucasians in the study reside in
“Telestroke Access” counties. The Charlson comorbidity index scores (high scores
indicate higher levels of comorbidity) were similar between the two groups, 1.53 in
counties with telestroke access compared to 1.57 in counties without telestroke access
(p=0.35). Stroke severity scores were also qualitatively similar 3.73 in counties with
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telestroke access compared to 3.46 in counties without telestroke access, however they
were statistically different between the groups (p=0.0043).
Out of the 9,311 stroke suffers only 461 (4.95%) were administered t-PA, which
is similar to published national benchmarks. When estimating the crude rate of t-PA
utilization a greater amount of patients that live in a county with “Telestroke Access”
more frequently received t-PA, 262 compared to 199 in no-access counties, however this
did not reach statistical significance (5.11% vs 4.76% respectively; p=0.45).
Figure 3. Adjusted Odds Ratio for Final Model “Odds of t-PA Use”
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In adjusted analysis, stroke patients hospitalized in telestroke access counties had
a 1.09 higher odds of receiving t-PA when compared to those hospitalized in counties
without telestroke access (AOR 1.09, 95% CI 0.90-1.32; p-value=0.34), however this did
not reach statistical significance (Figure 3). This multiple logistic regression model
controlled for Charleson comorbidity, stroke severity (SSI), age, and race.
Statistics of “Telestroke Access” Counties:
South Carolina is made up of 46 counties. In 2013 only 19 counties (41.30%)
provided access to telestroke and related resources. Of the 19 counties, 14 care for more
than 100 stroke patients as seen in Table 2. The first 4 counties combined treated the
majority of ischemic stroke patients, more than the other 15 counties combined. Three of
these four counties also surpassed the average total rate of t-PA administration (Table 3).
Discussion
After examination of the 2013 state of South Carolina’s HCUP SID data a total of
9,311 subjects were diagnosed with ischemic stroke. Of these subjects, only 262 (4.95%)
were administered t-PA, which is concordant with national benchmarks for t-PA
administration at 3-5% (Silva & Schwamm, 2012). When comparing the cohorts of
“Telestroke Access” to “No Telestroke Access” it was found that patients living in a
“Telestroke Access” counties do receive t-PA more frequently than the comparison
cohort, 5.11% vs. 4.76. However, after adjusted analysis these differences did not reach
statistical significant (p = 0.35). After completing the research and statistical analysis it
was determined the authors failed to reject the null hypothesis. This finding showed there
is no difference in rates of t-PA administration between stroke patients living in a South
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Carolina county with telestroke access vs. those living in a county without telestroke
access.
Limitations:
There exist a number of limitations in this study. Telestroke is not the only
variable that may influence t-PA usage, as recognition of signs and symptoms of stroke
are often not recognized, travel time from residence or site of occurrence to medical
facility can vary, by-passing properly prepared facilities by patient’s transport,
preparedness of emergency medical professional, and errors made during final coding of
the medical record may influence rates. These are examples that we could not be
controlled for in this study but are believed to have an impact on the amount of time it
takes a stroke patient to be seen and properly assessed. It must be kept in mind that
minutes matter in the course of a stroke; two million brain cells die every minute they are
starved oxygen (Morrissey, 2013). As the saying goes, “Time is Brain,” stroke patients
have a limited widow (3-4.5 hours) from symptom onset in which they are eligible to
receive t-PA and anything that delays their assessment and treatment is detrimental to
their surviving or suffering from the effects of the disease. Indication of non-significant
trend toward greater t-PA use among patients in telestroke counties may become
significant given a larger sample. This study may not have enough power to reject the
null hypothesis. It is recommended that researchers should use a larger sample size of
data when undertaking future studies in telestroke research.
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Conclusion:
We have determined by analyzing 2013 data from South Carolina living in a
county that has access to telestroke resources is not an indicator of increased likelihood of
receiving t-PA among acute ischemic stroke patients—which is believed to be
attributable to an insufficient sample size. Therefore, additional research on this topic
with a larger sample may be warranted. While this study did find a trend toward higher
rates rates of t-PA utilization in patients in counties with telestroke access, the finding
lacked statistical significance.
In the State of South Carolina, as well as many other regions across the United
States, funds may only be allocated to expand telestroke services if these services
improve patient care and outcomes—particularly in the rates of t-PA administration.
While this current study was not able to show a statistically-significant difference in rates
of t-PA administration between counties with and without telestroke access, perhaps
sufficiently powered future studies might show a difference. If a difference is found,
perhaps the national benchmark rate of t-PA administration could be increased from 35% of all acute ischemic strokes to a much higher rate.
Increasing the rate of t-PA administration to eligible acute ischemic stroke
patients would improve outcomes, and is the right thing to do for patients—as its
effectiveness has been demonstrated. t-PA is a lifesaving, “clot-busting” pharmaceutical
that has been proven to save stroke patients’ lives or reduce their degree or comorbidity.
In conclusion, stroke is a disease that is burdensome for the patient, the patient’s
loved ones, the healthcare system, and the nation as a whole. Telestroke has the ability to
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bridge many of the shortcomings realized by facilities have limited stroke professionals,
due to being geographically distant from larger cities or because of a lack of funds. Or
limited funds for advanced care teams. Evidence to support he benefit of telestroke
programs is essential for policymakers and hospital administrators to make the best
decisions given in environment of limited funding to care for their constitutes or the
communities they serve.
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